Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.
IPO Year: 2022
Exchange: NYSE
Website: https://www.haleon.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2026 | Equal Weight → Overweight | Barclays | |
| 9/16/2025 | Overweight → Equal Weight | Barclays | |
| 9/10/2025 | Neutral → Buy | Goldman | |
| 5/27/2025 | $13.40 | Neutral → Outperform | BNP Paribas Exane |
| 5/9/2025 | $11.25 | Equal-Weight → Overweight | Morgan Stanley |
| 3/5/2025 | Buy → Hold | HSBC Securities | |
| 1/10/2025 | Overweight → Equal-Weight | Morgan Stanley | |
| 1/8/2025 | Outperform → Mkt Perform | Bernstein | |
| 8/6/2024 | Buy → Neutral | Goldman | |
| 8/6/2024 | Buy | Berenberg |
Fastest customizable press release news feed in the world
New insights presented at The Consumer Goods Forum Global Summit highlight how AI is accelerating the convergence of global commerce models—reshaping growth strategies for brands and retailers NIQ (NYSE:NIQ), a leading consumer intelligence company, today revealed new analysis presented at The Consumer Goods Forum (CGF) Global Summit showing that nearly one in three consumers in Western markets now purchase products they first discover on social platforms, as artificial intelligence (AI) and emerging commerce models accelerate a shift toward discovery-led commerce. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626970024/en
The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like Key Takeaways: Advil is launching Rewriting Pain, a new campaign challenging sports culture's "no pain no gain" mentality and redefining strength as confronting pain, not ignoring it. New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. Legendary U.S. Men's National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and performance.
£175m for first Haleon manufacturing site in Madhya Pradesh, central India Fast-growing India key to Haleon reaching one billion more consumers by 2030 India's consumer health market to reach over £23bn by 20301 Accelerated rural distribution to access 3 million outlets Affordable Sensodyne packs and investment to double ‘last-mile' reach in rural areas Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building
Haleon (NYSE:HLN) is voluntarily recalling four lots of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct. distributed on or about April 13, 2026 to the consumer level. The lots are being recalled due to potential contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604056780/en/Gas-X Extra Strength Softgels (120 ct.) Front of Carton There is a potential that ingestion of the Softgels contaminated with the diluted propylene glycol-based coolant may result in adverse events such as nausea, vomiting, abdominal pain an
New campaign features global-inspired recipes, a multi-city food truck tour, creator collaborations, a sweepstakes and more, inspired by the summer's biggest soccer tournamentWARREN, N.J., June 3, 2026 /PRNewswire/ -- As soccer fans around the world gather to cheer on their favorite teams this summer, TUMS is bringing fans together over another shared passion: food. An extension of Haleon's partnership with U.S. Soccer, TUMS has announced the launch of the "TUMS Food Match Cup," a first-of-its-kind campaign inspired by the global flavors, traditions and team passions that make soccer's biggest tournament season unforgettable. From bold culinary mashups and creator collaborations to immersive
TORONTO, May 04, 2026 (GLOBE NEWSWIRE) -- Centrum, the #1 doctor and pharmacist recommended multivitamin brand in Canada, today announced the launch of Centrum Adults 50+ Complete Multivitamin, reformulated to support the changing nutritional and health needs of adults aged 50 and over, including memory and cognitive health. Developed with a comprehensive blend of essential vitamins and minerals, the formula supports areas of health as nutritional needs change with age. It includes Vitamin C and Zinc to support immune health, B vitamins to help with energy metabolism, Magnesium for muscle function, and Vitamin D and Calcium to help maintain bone strength. There is recent science-backed e
Today Haleon (NYSE:HLN), the consumer company that is solely focused on better everyday health, announced the appointment of Richard Manso as US Chief Marketing Officer, effective April 27, 2026. In this role, Manso will partner closely with CEO, US & President, North America Nathalie Gerschtein and the US leadership team to accelerate Haleon's evolution into a more agile, consumer-centric organization. Manso will lead Haleon's integrated US marketing organization, advancing how the company connects with consumers in the moments where health decisions actually happen. He will work across categories and global teams to integrate data, technology and human insight, strengthening Haleon's ab
From the gum expert brand, the new daily toothpaste and mouthwash help strengthen and protect gums, supporting healthy gum hydration, while featuring hyaluronic acid for enhanced foaming and freshness. Key Takeaways: parodontax expands its gum care portfolio with NEW Gum Strengthen & Protect Toothpaste and Mouthwash with Hyaluronic Acid^ Gum Strengthen & Protect is formulated to: Strengthen the gum seal for long-lasting gum protection with continued twice daily use Kill plaque bacteria along the gumline to support a stronger, tighter seal between gums and teeth with continued twice daily use Support healthy gum hydration Enhanced with Hyaluronic Acid^ as part of everyd
£65m investment in new oral health manufacturing plant in Shanghai to support growth in the world's largest gum health market Haleon aiming to extend gum health brand parodontax to 30 Chinese cities by end of 2027 - including its fastest growing cities – reaching aspirational shoppers in-store and online Custom designed taste, foamier sensation and premium packaging to appeal to local consumers Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing site in Shanghai. The facility will support the expansion of its oral care portfolio – which includes the global brands Sensodyne and p
An analysis of the COSMOS randomized trial provides early evidence that taking a daily multivitamin may help support healthy aging at the cellular level A new ancillary study published in Nature Medicine shows that Centrum Silver may slow biological aging markers. The findings come from an analysis of data from a randomized clinical trial, the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), designed to evaluate how daily multivitamin use may influence biological aging over time. Biological aging refers to how well the body is functioning at a cellular level and may add important information about health span than chronological age alone. Led by researchers at Mass General Bri
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
SD - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Barclays upgraded Haleon plc from Equal Weight to Overweight
Barclays downgraded Haleon plc from Overweight to Equal Weight
Goldman upgraded Haleon plc from Neutral to Buy
BNP Paribas Exane upgraded Haleon plc from Neutral to Outperform and set a new price target of $13.40
Morgan Stanley upgraded Haleon plc from Equal-Weight to Overweight and set a new price target of $11.25
HSBC Securities downgraded Haleon plc from Buy to Hold
Morgan Stanley downgraded Haleon plc from Overweight to Equal-Weight
Bernstein downgraded Haleon plc from Outperform to Mkt Perform
Goldman downgraded Haleon plc from Buy to Neutral
Berenberg initiated coverage of Haleon plc with a rating of Buy
Live Leadership Updates
Today Haleon (NYSE:HLN), the consumer company that is solely focused on better everyday health, announced the appointment of Richard Manso as US Chief Marketing Officer, effective April 27, 2026. In this role, Manso will partner closely with CEO, US & President, North America Nathalie Gerschtein and the US leadership team to accelerate Haleon's evolution into a more agile, consumer-centric organization. Manso will lead Haleon's integrated US marketing organization, advancing how the company connects with consumers in the moments where health decisions actually happen. He will work across categories and global teams to integrate data, technology and human insight, strengthening Haleon's ab
LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE:HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025. This appointment follows Franck Riot deciding to leave Haleon after six years in the business. Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P&G across Home, Health and Beauty Care. Brian McNamara, Haleon's Chief Executive Officer commented: "I am delighted to welcome Carl to Haleon. Carl is a world-renowned leader in R&D, with significant experi
WARREN, N.J., Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024. In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Joe brings extensive leadership experience to the role, having spent over 20 years in the FMCG sector and serving in the military. Most recently Joe led Unilever's Walmart business, overseeing the company's largest US customer. In his
Live finance-specific insights
BOSTON, June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its portfolio company, Suave Brands Company, has successfully completed the acquisition of the ChapStick brand from Haleon (NYSE:HLN). This transaction also results in Haleon becoming a shareholder in Suave Brands Company. Suave Brands Company Chief Executive Officer, Daniel Alter, said, "As we continue to build Suave Brands Company as the top independent North American beauty & personal care company by combining the agility of a start-up with the power of market leading brands, the addition of Cha
BOSTON, Jan. 25, 2024 /PRNewswire/ -- Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfolio company Suave Brands Company has signed a binding offer to acquire the ChapStick brand from Haleon (NYSE:HLN), a global leader in consumer health. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals. ChapStick invented the lip care category in the 1880s with the launch of a now-iconic lip balm that made ChapStick a household name. For more than a century, ChapStick has added products to its portfolio with innovative new i
Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice is for informational purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell, any securities. The exchange offers referred to herein are being made solely pursuant to the Prospectus and related documents. The exchange offers referred to herein are not being made to holders of securities in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. LONDON, Oct. 31, 2022 /PRNewswire/ -- Haleon plc ("Haleon
This live feed shows all institutional transactions in real time.
SC 13G - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)